Physician profile
Sergio A Martinez
NPI 1336171040
$41,142.41
in general payments reported to CMS, 2019-2025
40 companies · $1,718 in 2025
The $1,718 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $12K · 2021: $3,249 · 2022: $2,208 · 2023: $2,297 · 2024: $3,785 · 2025: $1,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,721 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,721.13 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $25,249.07 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $7,983.05 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,765.24 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,510.17 | 2021-2025 | |
| Glaxosmithkline, LLC. | $761.04 | 2019-2024 | Trelegy Ellipta, Nucala |
| Medtronic, INC. | $347.96 | 2021-2023 | Inpen Smart Insulin Delivery System |
| Amgen INC. | $305.78 | 2022-2023 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.31 | 2019-2025 | |
| Gilead Sciences, INC. | $249.21 | 2019-2021 | |
| Novo Nordisk INC | $222.47 | 2020-2025 | Ozempic, Rybelsus |
| Insmed, INC. | $219.43 | 2019-2025 | Arikayce |
| Baxter Healthcare | $187.44 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Abbott Laboratories | $177.26 | 2019-2024 | Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.59 | 2019-2022 | |
| Pfizer INC. | $152.84 | 2020-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.